Outcomes in UK ACS patients prescribed ticagrelor

Trial Identifier:	D5130R00027
Sponsor:	AstraZeneca
NCTID::	NCT03058601
Start Date:	January 2016
Primary Completion Date:	March 2016
Condition:	Coronary Artery Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
UK	Luton, UK

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.